Cornelia Dekker MD

Pediatric Infectious Disease•Half Moon Bay, CA

Pediatric Vaccinology and Vaccine Preventable Diseases, Perinatal Infections

Professor Emerita, Pediatrics - Infectious Diseases, Stanford University

Join to View Full Profile

24 Jenna LaneHalf Moon Bay, CA 94019
Phone+1 510-501-6323

Education & Training

Duke University HospitalFellowship, Pediatric Infectious Diseases, 1979 - 1982
Duke University HospitalResidency, Pediatrics, 1976 - 1979
Michigan State University College of Human MedicineClass of 1976

Certifications & Licensure

CA State Medical License 1998 - 2026
NC State Medical License 1977 - 1998
American Board of Pediatrics Pediatrics

Clinical Trials

B-cell Immunity to Influenza (SLVP017)- Year 1, 2009 Start of enrollment: 2009 Jul 01
Completed
Phase 4
The Influence of Chronic CMV Infection on Influenza Vaccine Responses Start of enrollment: 2012 Oct 01
Completed
Phase 4
Plasmablast Trafficking and Antibody Response in Influenza Vaccination (SLVP021 2011-2014) Start of enrollment: 2011 Aug 01
Completed
Phase 4
Pilot Study in Young Adults to Examine the Kinetics of Changes in the B-cell Repertoire Following TIV Immunization Start of enrollment: 2012 May 01
Completed
Phase 4
Kinetics of B-Cell Responses to Live, Attenuated Influenza Vaccine (LAIV) in Young Children Two Years of Age Start of enrollment: 2008 Nov 01
Terminated
Phase 4
B-cell Immunity to Influenza (SLVP017) - Years 2 (2010) & 3 (2011) Start of enrollment: 2010 Sep 01
Completed
Phase 4
B-cell Immunity to Influenza (SLVP017)- Year 5, 2013 Start of enrollment: 2013 Oct 01
Completed
Phase 4
T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 2, 2010 Start of enrollment: 2010 Sep 01
Completed
Phase 4
T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 3, 2011 Start of enrollment: 2011 Sep 01
Completed
Phase 4
T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 4, 2012 Start of enrollment: 2012 Oct 01
Completed
Phase 4
T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 5, 2013 Start of enrollment: 2013 Sep 01
Completed
Phase 4
The Human Mucosal Immune Responses to Influenza Virus (SLVP026) Start of enrollment: 2012 Dec 01
Completed
Phase 4
Protective Mechanisms Against a Pandemic Respiratory Virus (SLVP024) Start of enrollment: 2012 Oct 01
Completed
Phase 4
Tissue-specific Responses to Influenza Immunization and Their Relation to Blood Biomarkers (SLVP032) Start of enrollment: 2015 Sep 01
Terminated
Phase 4
Innate and Acquired Immunity to Influenza Infection and Immunization (SLVP029) Start of enrollment: 2014 Sep 17
Completed
Phase 4
Adaptive Immune Responses and Repertoire in Influenza Vaccination and Infection (SLVP031) Start of enrollment: 2014 Nov 19
Terminated
Phase 4
Genetic and Environmental Factors in the Response to Influenza Vaccination Start of enrollment: 2014 Oct 03
Completed
Phase 1
Effects of Aging on Primary and Secondary Vaccine Responses Start of enrollment: 2017 Sep 19
COMPLETED
PHASE1
The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination and Infection Start of enrollment: 2014 Sep 30
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

Age-dependent cytokine surge in blood precedes cancer diagnosis.
Guangbo Chen, Azam Mohsin, Hong Zheng, Yael Rosenberg-Hasson, Cindy Padilla
Proceedings of the National Academy of Sciences of the United States of America. 2025-03-25
Report of a SPEAC webinar 22 september 2023: Sensorineural hearing loss, lassa virus disease and vaccines.
Nicholas S Reed, Carmen C Brewer, Gideon Akintunde, Faustina F Blackie, Lovelyn Charles
Vaccine. 2025-01-01
1 citations
Coupling antigens from multiple subtypes of influenza can broaden antibody and T cell responses.
Vamsee Mallajosyula, Saborni Chakraborty, Elsa Sola, Ryan Furuichi Fong, Vishnu Shankar
Science. 2024-12-20

Press Mentions

Immune System “Clock” Predicts Illness and MortalityJuly 12th, 2021
Caffeine May Counter Age-Related InflammationJanuary 17th, 2017
T-cell and General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 2, 2010January 13th, 2017
Join now to see all